Suppr超能文献

前列环素(IP-)受体激动剂对大鼠结肠收缩性的抑制作用:非肾上腺素能非胆碱能神经传递的参与

Inhibition of rat colon contractility by prostacyclin (IP-) receptor agonists: involvement of NANC neurotransmission.

作者信息

Qian Y M, Jones R L

机构信息

Department of Pharmacology, Faculty of Medicine, Chinese University of Hong Kong, Shatin, NT.

出版信息

Br J Pharmacol. 1995 May;115(1):163-71. doi: 10.1111/j.1476-5381.1995.tb16334.x.

Abstract
  1. The possibility that prostacyclin (IP-) receptor agonists inhibit spontaneous contractions of the rat isolated colon by activating enteric neurones has been investigated. Cicaprost was used as the test agonist because of its high stability, selectivity and potency (IC50 = 3.8 nM). 2. The Na+ channel blockers saxitoxin (STX, 1 nM) and tetrodotoxin (TTX, 1 microM), whilst having little effect on resting spontaneous activity, virtually abolished the inhibitory actions of cicaprost (10 nM) and nicotine (3 microM); inhibitory responses to isoprenaline (20 nM) were not affected. Phentolamine (1 microM), propranolol (1 microM) and atropine (1 microM) had no effect on cicaprost inhibition. These data are compatible with release of inhibitory NANC transmitter(s) by cicaprost. 3. A transmitter role for nitric oxide was investigated. The nitric oxide synthase (NOS) inhibitor N omega-nitro-L-arginine methyl ester (L-NAME, 100 microM) inhibited the actions of both cicaprost (10 nM) and nicotine (3 microM) by 50-60%, but did not affect responses to isoprenaline (20 nM) or sodium nitroprusside (1-5 microM). The enantiomeric D-NAME (100 microM), which has negligible NOS inhibitory activity, had no effect on the action of cicaprost. 4. The involvement of purinergic transmitters was also investigated. Desensitization to the inhibitory action of ATP did not affect cicaprost responses. The P2x/P2y-receptor antagonist, suramin, at 300 microM blocked ATP responses, but not those due to adenosine; it did not affect cicaprost inhibition. The selective adenosine A1-receptor antagonist, DPCPX, used at a sufficiently high concentration (5 microM) to block adenosine A2-receptors, did not affect cicaprost inhibition. Apamin (25 nM), a blocker of calcium activated K+ channels on smooth muscle, abolished or markedly reduced the inhibitory actions of ATP and adenosine, and partially inhibited cicaprost and nicotine responses. The combination of L-NAME(100 microM) and apamin (25 nM) abolished cicaprost and nicotine responses.5. Investigation of vasoactive intestinal peptide (VIP) as a potential transmitter showed that its inhibitory action on the colon (IC50 = 50 nM) was partially inhibited by TTX (1 microM). alpha-Chymotrypsin abolished the effect of VIP but had no effect on cicaprost inhibition. Attempts to inhibit VIP responses using peptide antagonists and by agonist desensitization were unsuccessful.6. KCI (40 mM) contracted the colon and abolished spontaneous activity. Under these conditions,isoprenaline, sodium nitroprusside and ATP induced relaxation, whereas cicaprost (10-3 10 nM) had no effect. Cicaprost inhibited both the tone and the spontaneous activity induced by the EP1/EP3-receptor agonist, sulprostone (8.6 nM) but not when either TTX (1 microM) or KC1 (40 mM) was also present. On KCl-treated preparations, the prostacyclin analogue, iloprost (10-500 nM), induced contraction,presumably due to activation of EP-receptors.7. It is concluded that IP-receptor agonists inhibit the contractility of rat colon by stimulating the release of at least two transmitters from NANC enteric neurones. Nitric oxide appears to be one of the transmitters. The second transmitter mechanism is apamin-sensitive; the experimental results do not support ATP, adenosine or VIP as transmitter candidates. However, further studies using more potent and selective receptor antagonists are required.
摘要
  1. 已对前列环素(IP-)受体激动剂通过激活肠神经元来抑制大鼠离体结肠自发收缩的可能性进行了研究。西卡前列素因其高稳定性、选择性和效力(IC50 = 3.8 nM)而被用作测试激动剂。2. 钠通道阻滞剂石房蛤毒素(STX,1 nM)和河豚毒素(TTX,1 μM),虽然对静息自发活动影响很小,但几乎完全消除了西卡前列素(10 nM)和尼古丁(3 μM)的抑制作用;对异丙肾上腺素(20 nM)的抑制反应未受影响。酚妥拉明(1 μM)、普萘洛尔(1 μM)和阿托品(1 μM)对西卡前列素的抑制作用无影响。这些数据与西卡前列素释放抑制性非肾上腺素能非胆碱能(NANC)递质一致。3. 对一氧化氮的递质作用进行了研究。一氧化氮合酶(NOS)抑制剂Nω-硝基-L-精氨酸甲酯(L-NAME,100 μM)使西卡前列素(10 nM)和尼古丁(3 μM)的作用抑制50 - 60%,但不影响对异丙肾上腺素(20 nM)或硝普钠(1 - 5 μM)的反应。对NOS抑制活性可忽略不计的对映体D-NAME(100 μM)对西卡前列素的作用无影响。4. 还研究了嘌呤能递质的参与情况。对ATP抑制作用的脱敏不影响西卡前列素反应。300 μM的P2x/P2y受体拮抗剂苏拉明阻断了ATP反应,但不影响腺苷引起的反应;它不影响西卡前列素的抑制作用。选择性腺苷A1受体拮抗剂DPCPX,以足够高的浓度(5 μM)使用以阻断腺苷A2受体,不影响西卡前列素的抑制作用。阿帕明(25 nM),一种平滑肌上钙激活钾通道的阻滞剂,消除或显著降低了ATP和腺苷的抑制作用,并部分抑制了西卡前列素和尼古丁反应。L-NAME(100 μM)和阿帕明(25 nM)的组合消除了西卡前列素和尼古丁反应。5. 对血管活性肠肽(VIP)作为潜在递质的研究表明,其对结肠的抑制作用(IC50 = 50 nM)被TTX(1 μM)部分抑制。α-糜蛋白酶消除了VIP的作用,但对西卡前列素的抑制作用无影响。使用肽拮抗剂和通过激动剂脱敏来抑制VIP反应的尝试未成功。6. KCl(40 mM)使结肠收缩并消除自发活动。在这些条件下,异丙肾上腺素、硝普钠和ATP诱导舒张,而西卡前列素(10 - 3 10 nM)无作用。西卡前列素抑制了EP1/EP3受体激动剂舒前列素(8.6 nM)诱导的张力和自发活动,但当同时存在TTX(1 μM)或KCl(40 mM)时则无此作用。在KCl处理的制剂上,前列环素类似物伊洛前列素(10 - 500 nM)诱导收缩,推测是由于EP受体的激活。7. 得出结论,IP受体激动剂通过刺激NANC肠神经元释放至少两种递质来抑制大鼠结肠的收缩性。一氧化氮似乎是其中一种递质。第二种递质机制对阿帕明敏感;实验结果不支持ATP、腺苷或VIP作为递质候选物。然而,需要使用更有效和选择性更强的受体拮抗剂进行进一步研究。

相似文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验